Hwa Yeon Ko

7PUBLICATIONS
34CO-AUTHORS
Behavioural epidemiologyDisease surveillanceGene expression (incl. microarray and other genome-wide approaches)NeonatologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 30, 2026
Comparative hepatic effectiveness of empagliflozin vs dapagliflozin among individuals with type 2 diabetes and metabolic dysfunction-associated steatotic liver disease.

|Aug 18, 2025
Emulating Six Cardiovascular Outcome Trials of Antidiabetic Drugs in Individuals with Type 2 Diabetes: Analyses Based on Real-World Databases from Korea and Taiwan.

Hwa Yeon Ko, Philip C M Au, Michael Chun-Yuan Cheng

|Apr 28, 2025
Association between the body mass index and risk of cardiovascular events in sodium-glucose cotransporter 2 inhibitor users compared with dipeptidyl-peptidase 4 inhibitor users: A nationwide cohort study in Korea.

Hwa Yeon Ko, Kyungyeon Jung, Yongtai Cho

|Jan 21, 2025
Risk of Kawasaki Disease/Multisystem Inflammatory Syndrome Following COVID-19 Vaccination in Korean Children: A Self-Controlled Case Series Study.

Suyeon Kim, Hwa Yeon Ko, Jeongin Oh

|Sep 06, 2024
Risk of hepatic events associated with use of sodium-glucose cotransporter-2 inhibitors versus glucagon-like peptide-1 receptor agonists, and thiazolidinediones among patients with metabolic dysfunction-associated steatotic liver disease.

Sungho Bea, Hwa Yeon Ko, Jae Hyun Bae

|Sep 03, 2024
Treatment Patterns and Persistence Among Patients Newly Diagnosed With Migraine in South Korea: A Retrospective Analysis of Health Claims Data.

Ki Yeon Kim, Hwa Yeon Ko, Sungho Bea

Pageof 2

Frequent Collaborators

7 joint publications

Ju-Young Shin

5 joint publications

Sungho Bea

4 joint publications

Young Min Cho

3 joint publications

Jae Hyun Bae